e-learning
resources
ERJ
2010
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Iloprost-induced thrombocytopenia: a case proven by rechallenge
Taegtmeyer A.B., Zettler C., Siegemund M., Tsakiris D.A., Rätz Bravo A.E., Pargger H., Kraehenbuehl S., Haschke M.
Source:
Eur Respir J 2010; 36: 967-969
Journal Issue:
October
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Taegtmeyer A.B., Zettler C., Siegemund M., Tsakiris D.A., Rätz Bravo A.E., Pargger H., Kraehenbuehl S., Haschke M.. Iloprost-induced thrombocytopenia: a case proven by rechallenge. Eur Respir J 2010; 36: 967-969
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Osimertinib rechallenge under steroid protection following osimertinib-induced pneumonitis: Three case studies.
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021
A rare case of thrombocytopenia and pericaridal effusion
Source: International Congress 2019 – CCC Paediatric respiratory diseases
Year: 2019
C1-esterase inhibitor treatment for antibody-mediated rejection after lung transplantation: two case reports
Source: Eur Respir J, 55 (4) 1902027; 10.1183/13993003.02027-2019
Year: 2020
Gemcitabine induced pulmonary toxicity in a single patient: case report
Source: Eur Respir J 2006; 28: Suppl. 50, 753s
Year: 2006
Rifamycin induced leukocytoclastic vasculitis. A rare side-effect of anti-tuberculous chemotherapy
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016
A case with rifampicin induced severe trombocytopenia during tuberculosis treatment
Source: Annual Congress 2007 - Difficult tuberculosis cases I
Year: 2007
Consort hypersensitivity pneumonitis
Source: Eur Respir J 2009; 33: 1223-1225
Year: 2009
Ergoloid induced pleuropulmonary toxicity: Presentation of 3 cases and follow up
Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases
Year: 2010
Hypersensitivity pneumonitis associated with the use of temozolomide
Source: Eur Respir J 2009; 33: 931-934
Year: 2009
Clinical course in hypersensitivity pneumonitis: a review of 38 cases
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009
Severe asthma in old patients is characterized by signs of immunosuppression and by lymphocyte resistance to glucocorticoids
Source: Annual Congress 2012 - Aspects of clinical asthma
Year: 2012
Rifampicin related erythroderma in a patient with pulmonary tuberculosis with successful desensitisation: A case report and review of literature
Source: International Congress 2019 – CCC Respiratory infections
Year: 2019
Super-response to dupilumab therapy in a patient with severe asthma and ABPA – a case report
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020
Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia
Source: Eur Respir J, 52 (6) 1801482; 10.1183/13993003.01482-2018
Year: 2018
BCG-itis – rare side effect of vaccination
Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control
Year: 2007
Rituximab-induced lung disease: a systematic literature review
Source: Eur Respir J 2010; 35: 681-687
Year: 2010
Two rare hematological complications of tuberculosis: Immune hemolytic anemia and immune thrombocytopenic purpura
Source: Eur Respir J 2002; 20: Suppl. 38, 366s
Year: 2002
Sarcoidosis caused by interferon therapy: case report
Source: Eur Respir J 2003; 22: Suppl. 45, 233s
Year: 2003
A case report: disseminated tuberculosis in a 23 - year old man with hypersplenism
Source: Eur Respir J 2004; 24: Suppl. 48, 200s
Year: 2004
G-CSF enables completion of tuberculosis therapy associated with iatrogenic neutropenia
Source: Eur Respir J 2004; 23: 649-650
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept